February 22, 2017Calgary, Alberta: Novateqni Corporation ("Novateqni" or the "Company") (TSX-V:NTQ) announces that, pursuant to its stock option plan, it has granted stock options to acquire up to an aggregate of 1,325,000 common shares of the Company, of which 850,000 stock options were granted to certain directors and officers of the Company. Each of the stock options is exercisable for a five year term expiring on February 21, 2022, and exercisable until that time at a price of $0.25 per common share. On February 21, 2017, the closing price of Novateqni's common shares on the TSX Venture Exchange was $0.25 per share. The stock options vested immediately upon the date of grant. The stock options, and any common shares issued upon exercise of the stock options, are subject to a four month hold period expiring on June 21, 2017.

For further information, please contact Novateqni by email at info@novateqni.com.